Cipla has secured exclusive rights to distribute and market Afrezza, an inhalable insulin, in India. Developed by MannKind, Afrezza offers a non-injectable alternative for managing type 1 and type 2 diabetes. Clinical trials in India demonstrated its effectiveness in reducing HbA1c levels. Cipla aims to improve diabetes management accessibility with this innovative treatment.
Stock Radar: Muthoot Finance breaks out from inverse Head & shoulder pattern; time to buy?
Stocks to buy today: Wipro, L&T among top 9 trading ideas for 11 December 2024
The Indian market is expected to consolidate, with Nifty facing resistance at 24,850 and support at 24,400. Analysts suggest a trading range between 24,200 and 25,000. Several stocks are recommended for short-term trading, including Nippon Life, APL Apollo, and Jindal Steel.
Bullish Momentum: 7 stocks that formed White Marubozu Pattern on December 11
A White Marubozu is a bullish candlestick pattern in technical analysis. It occurs when the opening price is the lowest for a given period and the closing price is the highest.
Market to consolidate for another month, prioritise quality over momentum & value: Sunil Subramaniam
Market expert Sunil Subramaniam analyzes current market trends, citing low consumer spending, government underspending, and FII selling. He anticipates a market consolidation phase for another month, advising investors to prioritize quality stocks and remain patient. Subramaniam predicts increased government spending, improved earnings, and renewed FII interest by mid-January, driven by upcoming elections and budget expectations.
These 6 F&O stocks saw a high increase in futures open interest
This uptrend reflects an increasing number of participants either initiating new positions or expanding the size of their existing positions within the futures market.
Sleeping giant HDFC Bank shares wakes up with Rs 3 lakh crore rally
HDFC Bank’s shares surged by Rs 3 lakh crore in six months, reclaiming its position as a top wealth creator. The bank’s post-merger balance sheet is stronger, outperforming rivals with a 19% increase in share value. Brokerages predict further growth, setting target prices as high as Rs 2,550, driven by strong FII interest and resilient asset quality.
Consumption likely to see modest recovery in H2: Radhika Rao, DBS Bank
To make growth more sustainable, authorities will look to make recovery more broad-based, lifting investment growth along with consumption.
Mark Mobius says US Justice Department had no business prosecuting Adani Group; has a Santa gift for investors
Veteran investor Mark Mobius expresses skepticism about the US Justice Department’s involvement in probing an Indian company, Adani Group. He emphasizes the need for concrete evidence and anticipates a decrease in such international prosecutions under the Trump administration. Mobius highlights Adani’s infrastructure expertise and sees value in Indian power and telecom stocks, driven by growth and technological advancements.
Positive Breakout: These 5 stocks close cross above 200 DMAs
As long as the stock is priced above the 200-day SMA on the daily time frame, it is generally considered to be an overall uptrend.
